人人做天天爱夜夜爽2020

Medicine for treating high blood pressure. Might cause blood pressure to go lower than usual. Although this medicine was effective, the results from clinical trials show that this medicine was not suitable to be introduced to the market.

Anti-lymphoma medication. It kills healthy lymph easily and worsens the patient’s conditions. It also lowers the patient’s immunity. This medicine did not pass the first trial.

Anti-inflammation medicine for treating Prostatitis. It caused a heavy burden on the kidneys. This medicine might cure Prostatitis, but it will also cause kidney failures. The trial was stopped after the first phase.

Medicine for Cardiovascular disease. No obvious side effects., but the effectiveness of this medicine was not visible. After the first trial, this medicine was found to be heading in the wrong direction.

Behind every medicine listed, the reason for the failures was stated. The R&D cost of these medicines was also listed. Some of the developed medicines were not in the right direction and did not serve the purpose it was developed for. These medicines were still worth a bit of money.

Some of the medicines listed had side effects and could not pass the US FDA requirements. The researchers at Pfizer could not find any ways to lower the side effects, and all their effects in developing this medicine were wasted.

The R&D cost for these medicines was more than 100 million USD. Mark told Victor that this list was only part of their medications that were considered confirmed failures. If they include all the other half developed medicines, the cost will be much more than that.

These medicines that were on the list were mainly used by new researchers to practice.

This was common in R&D. Sometimes, effects and resources were wasted when the final product did not serve the purpose it was designed for. But if the final product was a success, the returns might reach more than 100 times its cost.

The cost used for developing these failed products could not be recovered in the past. But today, Victor said a Chinese businessman wants to buy these failed products. A stupid China businessman was willing to buy the formula of these failed products at high prices!

Although Mark was not convinced, he still followed George’s instructions to compile a list for Victor. If Victor could sell these failed products’ formula, they would be able to have more research funds for more new projects.

All the researchers’ salaries depend on the success of their R&D at Pfizer.

Victor read through the list and rearrange it before calling Feng Yu.

“Mr. Feng, I am Victor. I have convinced my CEO to sell you part of our research. When are you free to meet up for a discussion?”

Victor was impressed by Feng Yu. He saw Feng Yu traveling around with a convey and had dozens of bodyguards surrounding him. In China, firearms were banned. But those bodyguards’ suits were bulging and seems to be carrying weapons underneath.

Feng Yu was overjoyed when he received Victor’s call. His first step was considered a success.

Feng Yu immediately call his men to accompany him to meet Victor. He also hired a translator, although he does not need one.

……

“Mr. Feng, I am still at work and cannot leave my workplace. Thank you for coming over to my office?” Victor politely said. This was only a trip to his office at Pfizer. Was there a need to bring so many people along?

Feng Yu raised his brows. This Victor was very polite.

“It’s okay. If you can leave your office anything you want, you will also not be sent over to China to take charge of the operations here. Are the things I want ready?” Feng Yu asked eagerly.

“Mr. Feng, don’t be anxious. This is the list given by my company. Please take a look and see which medicines you are interested in.” Victor passed a piece of A4 paper to Feng Yu.

Feng Yu scanned through the list and saw a medicine for Cardiovascular disease. But he knows that Sildenafil was not included in the list.

Feng Yu pretended he did not understand the list and passed to his translator beside: “Help me take a look. What’s written in this paper?”

The translator read the list while Victor’s secretary poured coffee for Feng Yu. Victor invites Feng Yu to taste his coffee. Feng Yu took a sip. Too much sugar and milk were added to the coffee. Victor’s secretary was afraid that Feng Yu was not used to the taste of coffee, and she added more sugar and milk. But with more sugar and milk, the coffee tastes weird.

Feng Yu and Victor chatted for a while and during the conversation, Feng Yu “casually” mentioned how rich he was. Victor was smiling all along.

“Mr. Feng, there is 3 types of medicine on the list. The medicines are used to treat high blood pressure, Cardiovascular disease, and Lymphoma. But all these medicines are not developed successfully yet. It stopped halfway.” The translator whispered into Feng Yu’s ears.

Feng Yu pretended to frown. “An unfinished product? These are all half-developed products? Have the clinical trials started?”

“It is not stated in the list.”

Feng Yu turned to Victor: “Mr. Victor, have these drugs passed the clinical trials?”

Victor shook his head. “My company would not sell if these medicines entered clinical trials. These are still in the development phase. Because of limited resources and our company’s change in directions, the development of these medicines was stopped. This is why we are willing to sell them to you.”

Limited resources? Change in company’s direction? Bullshit!

These medicines should have gone through the clinical trials and found that it was not effective, or there were too many side effects. Pfizer is a big pharmaceutical company. Even if they have to stop the R&D on these drugs, they can also sell this research to other pharmaceutical factories or laboratories. Victor does not need to sell them to China. Pfizer could easily sell this research to the companies in the US.

“Mr. Victor, there are only 3 kinds of medicines? We are not interested in anti-cancer drugs. Currently, there are no effective anti-cancer drugs in the world. If your company’s research in this drug has no problems, you all will not stop the development of this medicine. As for the other two medicines which are used for treating high blood pressure and Cardiovascular disease, I need more detail information on the research. I will ask my researchers to go through the information before I can decide.” Feng Yu said after he pretended to discuss with the person beside him.

“This….. Ok. But the information cannot be taken out of our factory. I can bring your researchers to our laboratory to take a look. They will understand how much this drug is worth when they see the research data.” Victor replied. If he gave Feng Yu the information and data, Feng Yu’s researchers might discover that these drugs will not be developed successfully.

Feng Yu pretended to be troubled. “We still need to go to your laboratory? Fine. But can you prepare more medicines? It is a waste off time to visit your lab for just two medicines!”

Hahahaha……. Feng Yu knew that Victor will never give him the research data. What Feng Yu wanted was to visit Pfizer’s lab. Victor had finally invited him to visit his laboratory. I will be easier to deal with those nerdy researchers than a businessman!